NCT01916655 is a NA clinical trial of Self-Management Care in Obstructive Sleep Apnea, sponsored by VA Office of Research and Development.

Who is sponsoring NCT01916655?

NCT01916655 is sponsored by VA Office of Research and Development.

What drugs are being tested in NCT01916655?

Interventions in NCT01916655: Self-Management Care, Self-Management Mobile Care, Usual Care.

What condition does NCT01916655 study?

NCT01916655 studies Obstructive Sleep Apnea.

Is NCT01916655 still recruiting?

NCT01916655 is currently completed. Last updated 6 September 2019.

Are results published for NCT01916655?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-09-06 · How we verify

NCT01916655

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving the Frequency and Quality of Sleep Apnea Care Management

Completed NA Results posted Last updated 6 September 2019

What this trial tests

NA trial testing Self-Management Care in Obstructive Sleep Apnea in 360 participants. Completed in 30 March 2018.

Timeline

3 August 2015

Primary endpoint
30 December 2017

30 March 2018

Quick facts

Lead sponsor	VA Office of Research and Development
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	360
Start date	3 August 2015
Primary completion	30 December 2017
Estimated completion	30 March 2018
Sites	1 location across United States

Drugs / interventions tested

Self-Management Care
Self-Management Mobile Care
Usual Care

Conditions studied

Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Adults 18 to 85, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Positive Airway Pressure Adherence Primary · 2 month time point

objective measurement of the amount of time PAP therapy is used at the prescribed pressure

Group	Value	95% CI
Usual Care	3.9	± 2.2
Self-Management Care	3.9	± 2.4
Self-Management Mobile Care	3.8	± 2.4

Sponsor's own description

OSA is a major chronic condition affecting the quality of life of millions of Americans. Per the Institute of Medicine new treatment adherence strategies are needed to help improve the quality of care, reduce social and economic costs, and help those with chronic conditions (such as OSA) live healthier and more productive lives through better management of their conditions. Using an mHealth tool to help deliver the investigators' Self-Management intervention and improve the frequency and quality of patient-provider communications is a central component of that discovery process.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.
Askland K, Wright L, Wozniak DR, Emmanuel T, et al · · 2020 · cited 56× · PMID 32255210 · DOI 10.1002/14651858.cd007736.pub3
Telemedicine and the assessment of clinician time: a scoping review.
Kidholm K, Jensen LK, Johansson M, Montori VM. · · 2023 · cited 16× · PMID 38099431 · DOI 10.1017/s0266462323002830
Obstructive sleep apnea illness perception relative to other common chronic conditions.
Zamora T, Nokes B, Malhotra A, Stepnowsky C. · · 2025 · cited 1× · PMID 39297551 · DOI 10.5664/jcsm.11360

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting

Other VA Office of Research and Development trials

Trials by the same sponsor.

NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran · NA · not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness · NA · not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans · NA · not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01916655 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 6 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01916655.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing